Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02700113 · ClinicalTrials.gov registry record

Investigating Phenotypic Profiles of Children and Adolescents With ASD

A clinical trial, sponsored by Boston University Charles River Campus.

Completed
Registry status
72
Enrollment target

NCT02700113 is a clinical trial that has completed, run by Boston University Charles River Campus. The registered enrollment target is 72 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02700113 has completed, sponsored by Boston University Charles River Campus.

COMPLETED
Registry status
72 participants
Enrollment target

Study Summary

The purpose of this study is to provide a detailed description of language and cognitive profiles found among children and adolescents diagnosed with autism spectrum disorders (ASD). Participants with ASD ages 4-17;12 years who have limited verbal skills will be given comprehensive behavioral assessments to collect data that will advance our understanding of language-related processes in individuals with ASD, the knowledge of which will help in designing future interventions for this population.

Interventions

  • OTHER No intervention

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2014-11
Est. Completion 2019-08-30

What the Registry Record Tells You About NCT02700113

The ClinicalTrials.gov registry entry for NCT02700113 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University Charles River Campus, which has 104 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.

NCT02700113 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02700113 about?

NCT02700113 is a clinical study titled "Investigating Phenotypic Profiles of Children and Adolescents With ASD". The purpose of this study is to provide a detailed description of language and cognitive profiles found among children and adolescents diagnosed with autism spectrum disorders (ASD). Participants with ASD ages 4-17;12 years who have limited verbal skills will be given comprehensive behavioral assess...

What is the current status of trial NCT02700113?

This trial is currently completed. The enrollment target is 72 participants. The study started on 2014-11. Estimated completion is 2019-08-30.

What interventions are being tested in trial NCT02700113?

The interventions under investigation include: No intervention (OTHER).

Who is sponsoring clinical trial NCT02700113?

This trial is sponsored by Boston University Charles River Campus, which has 104 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.